Meeting commentary - Medicines for Older Adults: Learning from practice to develop patient centric drug products

John Wahlich, Sven Stegemann, Mine Orlu-Gul*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

A meeting jointly organised by the Academy of Pharmaceutical Sciences (APSGB), the Geriatric Medicine Society and the UCL School of Pharmacy took place on the 13th of March 2013, in Stevenage, UK. The meeting was attended by a number of experts involved with the treatment and development of drugs for the older adult, including clinicians, pharmacists, academics, regulators and representatives from industry. The event created the platform to discuss the provision of medicines for older adults from a pharmaceutical sciences perspective.

‘The use of medications in older patients is arguably the single most important health care intervention in the industrialized world
Original languageEnglish
Pages (from-to)251-257
JournalInternational Journal of Pharmaceutics
Volume456
Issue number1
DOIs
Publication statusPublished - 2013
Externally publishedYes

Fields of Expertise

  • Human- & Biotechnology

Treatment code (Nähere Zuordnung)

  • Basic - Fundamental (Grundlagenforschung)

Fingerprint

Dive into the research topics of 'Meeting commentary - Medicines for Older Adults: Learning from practice to develop patient centric drug products'. Together they form a unique fingerprint.

Cite this